AnaptysBio, Inc. (ANAB)
51.81
+0.45
(+0.88%)
USD |
NASDAQ |
Jun 09, 15:51
AnaptysBio SG&A Expense (Quarterly) : 26.20M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 6.86M |
| Vanda Pharmaceuticals, Inc. | 68.36M |
| Precision BioSciences, Inc. | 6.803M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |